FDA Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly
FDA Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly
MedShadow ArticlesRethinking Statins: Inside the Fierce Debate Over Cholesterol and Heart HealthKristel Tjandra and Gillian Dohrn
MedicationsINVESTIGATING GENERICS: Hundreds Of Drugs Remain On The Market After Fraudulent TrialsEmma Yasinski
Drug Interactions/Side EffectsSo, Your Doctor Wants You to Take a Statin. What Are the Risks?Dave Walker, RPh